Lista de obras - Marek Hus - Dominio Público Uruguay

1q21 amplification with additional genetic abnormalities but not isolated 1q21 gain is a negative prognostic factor in newly diagnosed patients with multiple myeloma treated with thalidomide-based regimens

artículo científico publicado en 2012

A Case Report of a Female Patient With Hodgkin Lymphoma Localized in the Central Nervous System and With Concomitant Pulmonary Lymphomatoid Granulomatosis

scientific article published on 08 September 2020

A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia - the TEAM-ET 2·0 trial

artículo científico publicado en 2019

ACE Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple Myeloma

artículo científico publicado en 2019

Acute T cell lymphoblastic leukemia in the recipient of a renal transplant from a donor with malignant lymphoma

artículo científico publicado en 2008

Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients.

artículo científico publicado en 2012

Advances in hematology – research that revolutionized patient care

artículo científico publicado en 2015

Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide study.

artículo científico publicado en 2019

An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma

artículo científico publicado en 2004

Assessment of micro RNAs expression in leukemic cells as prognostic markers in chronic lymphocytic leukemia: micro RNAs can predict survival in a course of the disease.

artículo científico publicado en 2018

Assessment of microRNA expression in leukemic cells as predictors of sensitivity to purine nucleoside analogs, fludarabine and cladribine, in chronic lymphocytic leukemia patients.

artículo científico publicado en 2019

Assessment of red blood cell distribution width as a prognostic marker in chronic lymphocytic leukemia

artículo científico publicado en 2016

Assessment of the efficacy of ofatumumab in patients with chronic lymphocytic leukaemia treated in the Department of Haematooncology and Bone Marrow Transplantation of the Medical University in Lublin - Prelimary results

artículo científico publicado en 2017

Autologous Hematopoietic Stem Cell Transplantation for Adults With Acute Myeloid Leukemia.

artículo científico publicado en 2016

Biosimilar granulocyte colony-stimulating factor is effective in reducing the duration of neutropenia after autologous peripheral blood stem cell transplantation.

artículo científico publicado en 2014

Cardiovascular dysfunction as a common cause of mortality in hypereosinophilic syndromes

artículo científico publicado en 2015

Central nervous involvement by chronic lymphocytic leukaemia.

artículo científico publicado en 2017

Changes in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells number

artículo científico publicado en 2017

Characteristics and clinical outcome of patients with hypereosinophilia of undetermined significance.

artículo científico publicado en 2013

Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group.

artículo científico publicado en 2017

Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma

artículo científico publicado en 2022

Clinical and immunologic characteristics of CD 34 positive acute myeloid leukemia

artículo científico publicado en 1995

Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript--results of Polish multicentre study.

artículo científico publicado en 2010

Cofilin-1 Maintains Prosurvival Signaling in Chronic Lymphocytic Leukemia Cells

scientific article published on 01 November 2020

Cytotoxic activity of valproic acid on primary chronic lymphocytic leukemia cells.

artículo científico publicado en 2015

Danazol induces apoptosis and cytotoxicity of leukemic cells alone and in combination with purine nucleoside analogs in chronic lymphocytic leukemia

artículo científico publicado en 2015

Diagnosis and treatment of acquired hemophilia: a single -center experience.

artículo científico publicado en 2017

Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia

artículo científico publicado en 2011

Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)

scientific article published on 29 October 2019

Efficacy and safety of lenalidomide treatment in multiple myeloma (MM) patients--Report of the Polish Myeloma Group

artículo científico publicado en 2015

Efficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG)

artículo científico publicado en 2017

Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors

artículo científico publicado en 2020

Expression and Clinical Significance of Neuropilin-1 in Patients With Multiple Myeloma

artículo científico publicado en 2020

Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma

scientific article published on 09 April 2020

Heterogeneity among characteristics of hypereosinophilic syndromes

artículo científico publicado en 2010

Hodgkin's variant of Richter's transformation during ibrutinib therapy in a series of CLL patients; the Polish Adult Leukemia Group report (PALG).

artículo científico publicado en 2017

Ibrutinib discontinuation in patients with relapsed or refractory chronic lymphocytic leukemia treated in a compassionate use program: A report from the Polish Adult Leukemia Study Group (PALG)

scientific article published on 01 August 2019

Imatinib discontinuation for hypereosinophilic syndrome harboring the FIP1L1-PDGFRA transcript

artículo científico publicado en 2015

Imatinib mesylate may induce long-term clinical response in FIP1L1-PDGFRα-negative hypereosinophilic syndrome.

artículo científico publicado en 2011

Infectious Complications in Patients With Multiple Myeloma After High-Dose Chemotherapy Followed by Autologous Stem Cell Transplant: Nationwide Study of the Infectious Complications Study Group of the Polish Adult Leukemia Group

artículo científico publicado en 2020

Influence of thalidomide on Bcl2 expression and proangiogenic cytokine levels in short-term culture of peripheral blood and bone marrow mononuclear cells of multiple myeloma patients.

artículo científico publicado en 2001

Interferon production by peripheral blood leukocytes of patients with acute myeloid leukemia

scientific article published on 01 January 1996

Intracellular IL-4 and IFN-γ expression in iNKT cells from patients with chronic lymphocytic leukemia

artículo científico publicado en 2017

Intraventricular treatment of secondary central nervous system lymphoma - Case study and literature overview

artículo científico publicado en 2018

Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study

artículo científico publicado en 2020

Long-term thalidomide therapy resulted in lack of mdr1 gene expression in a patient with primary resistant multiple myeloma.

artículo científico publicado en 2005

Low dose cytosine arabinoside in the treatment of the primary myelodysplastic syndrome

scientific article published on 01 January 1990

Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia

scientific article published on 12 October 2020

Minimally invasive, endovenous laser treatment of varicose veins in patients with von Willebrand disease

artículo científico publicado en 2013

New drugs in multiple myeloma - role of carfilzomib and pomalidomide

artículo científico

New prognostic biomarkers in multiple myeloma.

artículo científico publicado en 2016

Optimizing the treatment of patients with multiple myeloma and renal impairment

artículo científico

Physiological Performance of Pyrus pyraster L. (Burgsd.) and Sorbus torminalis (L.) Crantz Seedlings under Drought Treatment

artículo científico publicado en 2020

Polymorphisms in the promoter region of the CRBN gene as a predictive factor for the first-line CTD therapy in multiple myeloma patients.

artículo científico publicado en 2018

Polymorphisms in the promotor region of the CRBN gene as a predictive factor for peripheral neuropathy in the course of thalidomide-based chemotherapy in multiple myeloma patients

artículo científico publicado en 2019

Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib

artículo científico publicado en 2020

Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma.

artículo científico publicado en 2002

Profile of serum biomarkers in eosinophilic disorders

artículo científico publicado en 2016

Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen

scientific article published on 26 May 2020

Rapid reversal of quadraparesis in chronic eosinophilic leukaemia expressing the FIP1L1-PDGFRA transcript after therapy with imatinib.

artículo científico publicado en 2010

Rare case of Richter's syndrome localization in liver and thyroid of a patient with a chronic lymphocytic leukemia (CLL) - Case report and literature

scientific article published on 09 April 2019

Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma

artículo científico publicado en 2018

Serum brain-derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patients

scientific article published on 22 June 2020

Severe herpes simplex oral mucositis in a patient with non-Hodgkin’s lymphoma after autologous stem cells transplantation – Case Report

artículo científico publicado en 2017

Specific cytotoxic T-cell immune responses against autoantigens recognized by chronic lymphocytic leukaemia cells.

artículo científico publicado en 2016

Spontaneous and induced production of tumor necrosis factor (TNF alpha) by peripheral blood leukocytes in patients with acute leukemia type M 4 and M5 according to FAB

artículo científico publicado el 1 de enero de 1995

Stimulation of erythropoiesis by thalidomide in multiple myeloma patients: its influence on FasL, TRAIL and their receptors on erythroblasts.

artículo científico publicado en 2006

TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.

artículo científico publicado en 2018

TP53 polymorphism in plasma cell myeloma

artículo científico publicado en 2018

Thalidomide can promote erythropoiesis by induction of STAT5 and repression of external pathway of apoptosis resulting in increased expression of GATA-1 transcription factor

artículo científico publicado en 2015

Thalidomide treatment of resistant or relapsed multiple myeloma patients

artículo científico publicado en 2001

Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma.

artículo científico publicado en 2011

The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma

artículo científico publicado en 2019

The Impact of the NOD2/CARD15 Variant (3020insC) and PSMA6 Polymorphism (-8C>G) on the Development and Outcome of Multiple Myeloma

artículo científico publicado en 2020

The rate of in vitro fludarabine-induced peripheral blood and bone marrow cell apoptosis may predict the chemotherapy outcome in patients with chronic lymphocytic leukemia

artículo científico publicado en 2015

The role of immune checkpoint inhibitors in prostate cancer

scientific article published on 21 November 2018

Therapy - Related Myeloid Neoplasm in a Patient with Prior Treatment for Chronic Lymphocytic Leukemia: A Case Report

artículo científico publicado en 2017

Therapy-related peripheral neuropathy in multiple myeloma patients.

artículo científico publicado en 2014

Treatment of multiple myeloma patients with autologous stem cell transplantation - a fresh analysis.

artículo científico publicado en 2011

[Evaluation of blood morphology in patients with refractory multiple myeloma treated with thalidomide]

scientific article published on 01 July 2001

Lista de obras de Marek Hus

1q21 amplification with additional genetic abnormalities but not isolated 1q21 gain is a negative prognostic factor in newly diagnosed patients with multiple myeloma treated with thalidomide-based regimens

A Case Report of a Female Patient With Hodgkin Lymphoma Localized in the Central Nervous System and With Concomitant Pulmonary Lymphomatoid Granulomatosis

A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia - the TEAM-ET 2·0 trial

ACE Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple Myeloma

Acute T cell lymphoblastic leukemia in the recipient of a renal transplant from a donor with malignant lymphoma

Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients.

Advances in hematology – research that revolutionized patient care

Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide study.

An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma

Assessment of micro RNAs expression in leukemic cells as prognostic markers in chronic lymphocytic leukemia: micro RNAs can predict survival in a course of the disease.

Assessment of microRNA expression in leukemic cells as predictors of sensitivity to purine nucleoside analogs, fludarabine and cladribine, in chronic lymphocytic leukemia patients.

Assessment of red blood cell distribution width as a prognostic marker in chronic lymphocytic leukemia

Assessment of the efficacy of ofatumumab in patients with chronic lymphocytic leukaemia treated in the Department of Haematooncology and Bone Marrow Transplantation of the Medical University in Lublin - Prelimary results

Autologous Hematopoietic Stem Cell Transplantation for Adults With Acute Myeloid Leukemia.

Biosimilar granulocyte colony-stimulating factor is effective in reducing the duration of neutropenia after autologous peripheral blood stem cell transplantation.

Cardiovascular dysfunction as a common cause of mortality in hypereosinophilic syndromes

Central nervous involvement by chronic lymphocytic leukaemia.

Changes in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells number

Characteristics and clinical outcome of patients with hypereosinophilia of undetermined significance.

Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group.

Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma

Clinical and immunologic characteristics of CD 34 positive acute myeloid leukemia

Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript--results of Polish multicentre study.

Cofilin-1 Maintains Prosurvival Signaling in Chronic Lymphocytic Leukemia Cells

Cytotoxic activity of valproic acid on primary chronic lymphocytic leukemia cells.

Danazol induces apoptosis and cytotoxicity of leukemic cells alone and in combination with purine nucleoside analogs in chronic lymphocytic leukemia

Diagnosis and treatment of acquired hemophilia: a single -center experience.

Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia

Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)

Efficacy and safety of lenalidomide treatment in multiple myeloma (MM) patients--Report of the Polish Myeloma Group

Efficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG)

Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors

Expression and Clinical Significance of Neuropilin-1 in Patients With Multiple Myeloma

Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma

Heterogeneity among characteristics of hypereosinophilic syndromes

Hodgkin's variant of Richter's transformation during ibrutinib therapy in a series of CLL patients; the Polish Adult Leukemia Group report (PALG).

Ibrutinib discontinuation in patients with relapsed or refractory chronic lymphocytic leukemia treated in a compassionate use program: A report from the Polish Adult Leukemia Study Group (PALG)

Imatinib discontinuation for hypereosinophilic syndrome harboring the FIP1L1-PDGFRA transcript

Imatinib mesylate may induce long-term clinical response in FIP1L1-PDGFRα-negative hypereosinophilic syndrome.

Infectious Complications in Patients With Multiple Myeloma After High-Dose Chemotherapy Followed by Autologous Stem Cell Transplant: Nationwide Study of the Infectious Complications Study Group of the Polish Adult Leukemia Group

Influence of thalidomide on Bcl2 expression and proangiogenic cytokine levels in short-term culture of peripheral blood and bone marrow mononuclear cells of multiple myeloma patients.

Interferon production by peripheral blood leukocytes of patients with acute myeloid leukemia

Intracellular IL-4 and IFN-γ expression in iNKT cells from patients with chronic lymphocytic leukemia

Intraventricular treatment of secondary central nervous system lymphoma - Case study and literature overview

Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study

Long-term thalidomide therapy resulted in lack of mdr1 gene expression in a patient with primary resistant multiple myeloma.

Low dose cytosine arabinoside in the treatment of the primary myelodysplastic syndrome

Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia

Minimally invasive, endovenous laser treatment of varicose veins in patients with von Willebrand disease

New drugs in multiple myeloma - role of carfilzomib and pomalidomide

New prognostic biomarkers in multiple myeloma.

Optimizing the treatment of patients with multiple myeloma and renal impairment

Physiological Performance of Pyrus pyraster L. (Burgsd.) and Sorbus torminalis (L.) Crantz Seedlings under Drought Treatment

Polymorphisms in the promoter region of the CRBN gene as a predictive factor for the first-line CTD therapy in multiple myeloma patients.

Polymorphisms in the promotor region of the CRBN gene as a predictive factor for peripheral neuropathy in the course of thalidomide-based chemotherapy in multiple myeloma patients

Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib

Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma.

Profile of serum biomarkers in eosinophilic disorders

Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen

Rapid reversal of quadraparesis in chronic eosinophilic leukaemia expressing the FIP1L1-PDGFRA transcript after therapy with imatinib.

Rare case of Richter's syndrome localization in liver and thyroid of a patient with a chronic lymphocytic leukemia (CLL) - Case report and literature

Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma

Serum brain-derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patients

Severe herpes simplex oral mucositis in a patient with non-Hodgkin’s lymphoma after autologous stem cells transplantation – Case Report

Specific cytotoxic T-cell immune responses against autoantigens recognized by chronic lymphocytic leukaemia cells.

Spontaneous and induced production of tumor necrosis factor (TNF alpha) by peripheral blood leukocytes in patients with acute leukemia type M 4 and M5 according to FAB

Stimulation of erythropoiesis by thalidomide in multiple myeloma patients: its influence on FasL, TRAIL and their receptors on erythroblasts.

TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.

TP53 polymorphism in plasma cell myeloma

Thalidomide can promote erythropoiesis by induction of STAT5 and repression of external pathway of apoptosis resulting in increased expression of GATA-1 transcription factor

Thalidomide treatment of resistant or relapsed multiple myeloma patients

Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma.

The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma

The Impact of the NOD2/CARD15 Variant (3020insC) and PSMA6 Polymorphism (-8C>G) on the Development and Outcome of Multiple Myeloma

The rate of in vitro fludarabine-induced peripheral blood and bone marrow cell apoptosis may predict the chemotherapy outcome in patients with chronic lymphocytic leukemia

The role of immune checkpoint inhibitors in prostate cancer

Therapy - Related Myeloid Neoplasm in a Patient with Prior Treatment for Chronic Lymphocytic Leukemia: A Case Report

Therapy-related peripheral neuropathy in multiple myeloma patients.

Treatment of multiple myeloma patients with autologous stem cell transplantation - a fresh analysis.